
ARDT
Ardent Health Inc
- Overview
- Forecast
- Valuation
- Earnings

Line
|

Candle
1D
5D
1M
3M
6M
YTD
1Y
5Y
High
11.070
Open
10.780
VWAP
10.98
Vol
447.46K
Mkt Cap
1.58B
Low
10.750
Amount
4.91M
EV/EBITDA(TTM)
4.80
Total Shares
143.04M
EV
2.55B
EV/OCF(TTM)
8.35
P/S(TTM)
0.25
Ardent Health, Inc., formerly Ardent Health Partners, Inc., is a provider of healthcare in mid-sized urban communities across the United States. Through its subsidiaries, the Company delivers care through a system of 30 acute care hospitals and approximately 280 sites of care with over 1,800 affiliated providers across six states. It provides both general and specialty services, including internal medicine, general surgery, cardiology, oncology, orthopedics, women’s services, neurology, urology, and emergency services, within inpatient and ambulatory care settings. In addition to its 30 acute care hospitals, it operates a network of ambulatory facilities and telehealth services, including primary care and specialty care clinics, ambulatory surgery centers (ASCs), urgent care centers, free-standing emergency departments, and diagnostic imaging centers. It operates a consumer-centric healthcare platform focused on creating relationships with its patients across multiple care settings.
Show More
8 Analyst Rating

86.26% Upside
Wall Street analysts forecast ARDT stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for ARDT is 20.60 USD with a low forecast of 18.00 USD and a high forecast of 24.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
7 Buy
1 Hold
0 Sell
Strong Buy

86.26% Upside
Current: 11.060

Low
18.00
Averages
20.60
High
24.00

86.26% Upside
Current: 11.060

Low
18.00
Averages
20.60
High
24.00
BofA
Neutral -> Underperform
downgrade
$146
2025-07-16
Reason
BofA
Price Target
$146
2025-07-16
downgrade
Neutral -> Underperform
Reason
BofA downgraded Ardent Health to Underperform from Neutral with a $146 price target.
BofA
Joanna Gajuk
Neutral -> Underperform
downgrade
2025-07-16
Reason
BofA
Joanna Gajuk
Price Target
2025-07-16
downgrade
Neutral -> Underperform
Reason
BofA analyst Joanna Gajuk downgraded Ardent Health to Underperform from Neutral with a price target of $14.60, down from $15.50. The firm downgraded four healthcare facility and managed care stocks that it believes are most exposed to the One Big Beautiful Bill. The bill has a board range of negative implications and creates downside risk to growth estimates for the sector, the analyst tells investors in a research note. The subsidy cuts to Medicaid and Affordable Care Act exchanges are not reflected in consensus estimates and for many companies not reflected in stock prices, contends BofA.
Guggenheim
Buy
maintain
$16 -> $18
2025-05-09
Reason
Guggenheim
Price Target
$16 -> $18
2025-05-09
maintain
Buy
Reason
Guggenheim
Jason Cassorla
Strong Buy
Initiates
$16
2025-04-09
Reason
Guggenheim
Jason Cassorla
Price Target
$16
2025-04-09
Initiates
Strong Buy
Reason
Mizuho
Ann Hynes
Buy
Maintains
$19 → $18
2025-04-09
Reason
Mizuho
Ann Hynes
Price Target
$19 → $18
2025-04-09
Maintains
Buy
Reason
Mizuho lowered the firm's price target on Ardent Health to $18 from $19 and keeps an Outperform rating on the shares. The firm surveyed 215 physicians over 13 specialties to gauge hospital inpatient and outpatient trends during Q1. The survey suggests both inpatient and outpatient growth trends, while still elevated, appear to have peaked, the analyst tells investors in a research note. Mizuho views the survey as positive for managed care and clinical labs and neutral for hospitals.
Stephens & Co.
Scott Fidel
Buy
Reiterates
$22
2025-04-01
Reason
Stephens & Co.
Scott Fidel
Price Target
$22
2025-04-01
Reiterates
Buy
Reason
Virtual Meeting to be held on March 25 hosted by Stephens.
See All Ratings
Valuation Metrics
The current forward P/E ratio for Ardent Health Inc (ARDT.N) is 5.25, compared to its 5-year average forward P/E of 8.55. For a more detailed relative valuation and DCF analysis to assess Ardent Health Inc 's fair value, click here.
Forward PE
The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.

Undervalued
5Y Average PE
8.55
Current PE
5.25
Overvalued PE
10.31
Undervalued PE
6.79
Forward EV/EBITDA
The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.

Undervalued
5Y Average EV/EBITDA
7.86
Current EV/EBITDA
5.89
Overvalued EV/EBITDA
9.12
Undervalued EV/EBITDA
6.60
Forward PS
The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.

Strongly Undervalued
5Y Average PS
0.36
Current PS
0.23
Overvalued PS
0.41
Undervalued PS
0.30
Financials
Annual
Quarterly
FY2025Q1
YoY :
+4.04%
1.50B
Total Revenue
FY2025Q1
YoY :
-36.29%
48.31M
Operating Profit
FY2025Q1
YoY :
+28.60%
58.97M
Net Income after Tax
FY2025Q1
YoY :
+52.63%
0.29
EPS - Diluted
FY2025Q1
YoY :
+23.80%
-47.70M
Free Cash Flow
FY2025Q1
YoY :
-1.27%
53.66
Gross Profit Margin - %
FY2025Q1
1.96
FCF Margin - %
FY2025Q1
YoY :
+23.51%
3.94
Net Margin - %
FY2025Q1
11.04
ROIC
Trading Trends
Insider
Insiders are Neutral. There are no significant trading trends over the last month.
Sold
0-3
Months
0.0
USD
0
3-6
Months
0.0
USD
0
6-9
Months
0.0
USD
0
0-12
Months
0.0
USD
0
Bought
0-3
0
0.0
USD
Months
3-6
0
0.0
USD
Months
6-9
1
339.6K
USD
Months
0-12
0
0.0
USD
Months
Hedge Fund
Hedge Funds are Neutral. There are no significant trading trends over the last quarter.
Sold
0-3
Months
0.0
Volume
0
3-6
Months
0.0
Volume
0
6-9
Months
0.0
Volume
0
0-12
Months
0.0
Volume
0
Bought
0-3
0
0.0
Volume
Months
3-6
0
0.0
Volume
Months
6-9
1
100.0K
Volume
Months
0-12
0
0.0
Volume
Months
Congress Trading
Congress are Neutral. There are no significant trading trends over the last month.
Sold
0-3
Months
0.0
USD
0
3-6
Months
0.0
USD
0
6-9
Months
0.0
USD
0
0-12
Months
0.0
USD
0
Bought
0-3
0
0.0
USD
Months
3-6
0
0.0
USD
Months
6-9
0
0.0
USD
Months
0-12
0
0.0
USD
Months
Insider
Insiders are Neutral. There are no significant trading trends over the last month.
Sold
0-3
Months
0.0
USD
0
3-6
Months
0.0
USD
0
6-9
Months
0.0
USD
0
0-12
Months
0.0
USD
0
Bought
0-3
0
0.0
USD
Months
3-6
0
0.0
USD
Months
6-9
1
339.6K
USD
Months
0-12
0
0.0
USD
Months
ARDT News & Events
Events Timeline
2025-07-16 (ET)
2025-07-16
12:00:03
Ardent Health falls -13.4%

2025-07-16
10:46:13
Ardent Health falls -11.8%

2025-06-09 (ET)
2025-06-09
10:00:47
Ardent Health falls -7.3%

Sign Up For More Events
Sign Up For More Events
News
2.0
07-17NASDAQ.COMOversold Conditions For Ardent Health (ARDT)
3.5
05-27WSJWhy AI May Be Listening In on Your Next Doctor’s Appointment
2.0
05-23NewsfilterArdent Health Partners, Inc. Updates Name to Ardent Health, Inc.
Sign Up For More News
People Also Watch

APLD
Applied Digital Corp
10.750
USD
-4.02%

UTZ
UTZ Brands Inc
14.320
USD
-0.97%

CEPU
Central Puerto SA
12.100
USD
+1.00%

HSAI
Hesai Group
21.300
USD
0.00%

CNTA
Centessa Pharmaceuticals PLC
15.410
USD
-0.45%

WLY
John Wiley & Sons Inc
39.200
USD
-0.58%

GTX
Garrett Motion Inc
12.940
USD
+6.15%

ZIM
ZIM Integrated Shipping Services Ltd
16.730
USD
+1.46%

NPWR
NET Power Inc
2.800
USD
+2.19%

FWONA
Formula One Group
92.700
USD
-0.89%
FAQ

What is Ardent Health Inc (ARDT) stock price today?
The current price of ARDT is 11.06 USD — it has increased 2.5 % in the last trading day.

What is Ardent Health Inc (ARDT)'s business?

What is the price predicton of ARDT Stock?

What is Ardent Health Inc (ARDT)'s revenue for the last quarter?

What is Ardent Health Inc (ARDT)'s earnings per share (EPS) for the last quarter?

What changes have occurred in the market's expectations for Ardent Health Inc (ARDT)'s fundamentals?

How many employees does Ardent Health Inc (ARDT). have?
